跳至主要内容
临床试验/NCT02551406
NCT02551406已完成不适用

Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients

Centre d'Investigation Clinique et Technologique 8051 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
试验地点
1
主要终点
Time to first ICU admission

研究概览

简要总结

Different tools may be used to monitor the efficacy of home mechanical ventilation. Investigators aimed to compare the prognostic value of the different data obtained by capno-oxymetry in a mechanical ventilated neuromuscular disease's population.

详细描述

Home mechanical ventilation (HMV) is used to treat hypoventilation, and its efficacy is mostly assessed by daytime blood gases and nocturnal oxymetry (SpO2). Transcutaneous CO2 measure (TcCO2) has shown higher sensitivity than SpO2 to detect hypoventilation in neuromuscular diseases (NMD) patients. No data exist on the prognostic value of these techniques to monitor mechanical ventilated NMD patients.

Basing on retrospective data review, investigators aimed to compare the prognostic value of the data obtained using different tools to assess residual hypoventilation in the cohort of ventilated NMD patients followed at our reference center.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • neuromuscular disease
  • age ≥18 years
  • mechanically ventilated
  • capno-oxymetry performed between 2009 and 2011

排除标准

  • Long-term oxygen therapy

结局指标

主要结局

Time to first ICU admission

时间窗: 6 years

Time to first ICU admission

次要结局

  • Mortality(6 years)

研究者

发起方
Centre d'Investigation Clinique et Technologique 805
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验